The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Prostate Cancer
Open accessAbstract
In the late 1980s and early 1990s, the number of newly diagnosed prostate cancers in the United States increased dramatically, surpassing lung cancer as the most common cancer in men. 1 Experts generally believe that these changes resulted from prostate-specific antigen (PSA) screening that detected many earlystage prostate cancers.For example, the percentage of patients with low-risk disease has increased (45.3% in 1999-2001 vs. 29.8% in 1989-1992; P < .0001). 2 The incidence of prostate cancer increased 2.0% annually from 1995 to 2001 and has since declined.In 2009, an estimated 192,280 new cases were diagnosed and prostate cancer was expected to account for 25% of new cancer cases in men. 1 Fortunately, the age-adjusted death rates from prostate cancer have also declined (-4.1% annually from 1994 to 2001).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
American Joint Committee on Cancer (2002) · Springer eBooks · doi:10.1007/978-1-4757-3656-4 · Cited by 6,379
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
Tannock, I. F., de Wit, R., Berry, W. R., Horti, J., Pluzanska, A., Chi, K. N., Oudard, S., Théodore, C., James, N. D., Turesson, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040720 · Cited by 5,735
D'Amico, A. V. (1998) · JAMA · doi:10.1001/jama.280.11.969 · Cited by 4,523
Self-citationScreening and Prostate-Cancer Mortality in a Randomized European Study
Schröder, F. H., Hugosson, J., Roobol, M. J., Tammela, T. L. J., Ciatto, S., Nelen, V., Kwiatkowski, M., Lujan, M., Lilja, H., Zappa, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810084 · Cited by 4,014
Petrylak, D. P., Tangen, C. M., Hussain, M. H. A., Lara, P. N., Jones, J. A., Taplin, M. E., Burch, P. A., Berry, D., Moinpour, C., Kohli, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041318 · Cited by 3,665
Natural History of Progression After PSA Elevation Following Radical Prostatectomy
Pound, C. R. (1999) · JAMA · doi:10.1001/jama.281.17.1591 · Cited by 3,071
Marx, R. E. (2003) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/s0278-2391(03)00720-1 · Cited by 3,036
Mortality Results from a Randomized Prostate-Cancer Screening Trial
Andriole, G. L., Crawford, E. D., Grubb, R. L., Buys, S. S., Chia, D., Church, T. R., Fouad, M. N., Gelmann, E. P., Kvale, P. A., Reding, D. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810696 · Cited by 2,906
Roach, M., Hanks, G., Thames, H., Schellhammer, P., Shipley, W. U., Sokol, G. H., & Sandler, H. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.04.029 · Cited by 2,749
Self-citationQuality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors
Sanda, M. G., Dunn, R. L., Michalski, J., Sandler, H. M., Northouse, L., Hembroff, L., Lin, X., Greenfield, T. K., Litwin, M. S., Saigal, C. S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074311 · Cited by 2,253
Saad, F., Gleason, D. M., Murray, R., Tchekmedyian, S., Venner, P., Lacombe, L., Chin, J. L., Vinholes, J. J., Goas, J. A., & Chen, B. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.19.1458 · Cited by 1,656
Bolla, M., Gonzalez, D., Warde, P., Dubois, J. B., Mirimanoff, R.-O., Storme, G., Bernier, J., Kuten, A., Sternberg, C., Gil, T., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707313370502 · Cited by 1,548
Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer
Keating, N. L., O'Malley, A. J., & Smith, M. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.2497 · Cited by 1,455
Self-citationRisk of Fracture after Androgen Deprivation for Prostate Cancer
Shahinian, V. B., Kuo, Y.-F., Freeman, J. L., & Goodwin, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041943 · Cited by 1,375
Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer
Kuban, D. A., Tucker, S. L., Dong, L., Starkschall, G., Huang, E. H., Cheung, M. R., Lee, A. K., & Pollack, A. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.06.054 · Cited by 1,232
Thompson, I. M., Tangen, C. M., Paradelo, J., Lucia, M. S., Miller, G., Troyer, D., Messing, E., Forman, J., Chin, J., Swanson, G., et al. (2009) · Journal of Urology · doi:10.1016/j.juro.2008.11.032 · Cited by 1,227
Saad, F., Gleason, D. M., Murray, R., Tchekmedyian, S., Venner, P., Lacombe, L., Chin, J. L., Vinholes, J. J., Goas, J. A., & Zheng, M. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh141 · Cited by 1,201
20-Year Outcomes Following Conservative Management of Clinically Localized Prostate Cancer
Albertsen, P. C. (2005) · JAMA · doi:10.1001/jama.293.17.2095 · Cited by 1,187
Catalona, W. J., Partin, A. W., Slawin, K. M., Brawer, M. K., Flanigan, R. C., Patel, A., Richie, J. P., deKernion, J. B., Walsh, P. C., Scardino, P. T., et al. (1998) · JAMA · doi:10.1001/jama.279.19.1542 · Cited by 1,162
Self-citationBerthold, D. R., Pond, G. R., Soban, F., de Wit, R., Eisenberger, M., & Tannock, I. F. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.4008 · Cited by 1,145
Denosumab in men receiving androgen-deprivation therapy for prostate cancer
Smith, M. R., Egerdie, B., Toriz, N. H., Feldman, R., Tammela, T. L. J., Saad, F., Heracek, J., Szwedowski, M., Ke, C., Kupic, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809003 · Cited by 1,140
Self-citationDraisma, G., Boer, R., Otto, S. J., van der Cruijsen, I. W., Damhuis, R. A. M., Schroder, F. H., & de Koning, H. J. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.12.868 · Cited by 1,071
Kantoff, P. W., Schuetz, T. J., Blumenstein, B. A., Glode, L. M., Bilhartz, D. L., Wyand, M., Manson, K., Panicali, D. L., Laus, R., Schlom, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.0597 · Cited by 982
Self-citationDuration of Androgen Suppression in the Treatment of Prostate Cancer
Bolla, M., de Reijke, T. M., Van Tienhoven, G., Van den Bergh, A. C. M., Oddens, J., Poortmans, P. M. P., Gez, E., Kil, P., Akdas, A., Soete, G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810095 · Cited by 970
Peeters, S. T. H., Heemsbergen, W. D., Koper, P. C. M., van Putten, W. L. J., Slot, A., Dielwart, M. F. H., Bonfrer, J. M. G., Incrocci, L., & Lebesque, J. V. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.2530 · Cited by 966
Results of Conservative Management of Clinically Localized Prostate Cancer
Chodak, G. W., Thisted, R. A., Gerber, G. S., Johansson, J.-E., Adolfsson, J., Jones, G. W., Chisholm, G. D., Moskovitz, B., Livne, P. M., & Warner, J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401273300403 · Cited by 928
Messing, E. M., Manola, J., Yao, J., Kiernan, M., Crawford, D., Wilding, G., di'SantAgnese, P. A., & Trump, D. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70700-8 · Cited by 893
Stephenson, A. J., Scardino, P. T., Kattan, M. W., Pisansky, T. M., Slawin, K. M., Klein, E. A., Anscher, M. S., Michalski, J. M., Sandler, H. M., Lin, D. W., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.9607 · Cited by 888
Intravenous Zoledronic Acid in Postmenopausal Women with Low Bone Mineral Density
Reid, I. R., Brown, J. P., Burckhardt, P., Horowitz, Z., Richardson, P., Trechsel, U., Widmer, A., Devogelaer, J.-P., Kaufman, J.-M., Jaeger, P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011807 · Cited by 877
Widmark, A., Klepp, O., Solberg, A., Damber, J.-E., Angelsen, A., Fransson, P., Lund, J.-Å., Tasdemir, I., Hoyer, M., Wiklund, F., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61815-2 · Cited by 876
Wiegel, T., Bottke, D., Steiner, U., Siegmann, A., Golz, R., Störkel, S., Willich, N., Semjonow, A., Souchon, R., Stöckle, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.9563 · Cited by 825
Randomized Trial of Short- Versus Long-Course Radiotherapy for Palliation of Painful Bone Metastases
Hartsell, W. F., Scott, C. B., Bruner, D. W., Scarantino, C. W., Ivker, R. A., Roach, M., Suh, J. H., Demas, W. F., Movsas, B., Petersen, I. A., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji139 · Cited by 823
Self-citationComparative Effectiveness of Minimally Invasive vs Open Radical Prostatectomy
Hu, J. C. (2009) · JAMA · doi:10.1001/jama.2009.1451 · Cited by 816
Development and Validation of a Prognostic Index for 4-Year Mortality in Older Adults
Lee, S. J. (2006) · JAMA · doi:10.1001/jama.295.7.801 · Cited by 809
Draisma, G., Etzioni, R., Tsodikov, A., Mariotto, A., Wever, E., Gulati, R., Feuer, E., & de Koning, H. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp001 · Cited by 796
Preoperative PSA Velocity and the Risk of Death from Prostate Cancer after Radical Prostatectomy
D'Amico, A. V., Chen, M.-H., Roehl, K. A., & Catalona, W. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032975 · Cited by 740
Self-citationDearnaley, D. P., Khoo, V. S., Norman, A. R., Meyer, L., Nahum, A., Tait, D., Yarnold, J., & Horwich, A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05180-0 · Cited by 739
Natural History of Early, Localized Prostate Cancer
Johansson, J.-E. (2004) · JAMA · doi:10.1001/jama.291.22.2713 · Cited by 703
Changes in body composition during androgen deprivation therapy for prostate cancer
Smith, M. R., Finkelstein, J. S., McGovern, F. J., Zietman, A. L., Fallon, M. A., Schoenfeld, D. A., & Kantoff, P. W. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8299 · Cited by 697
Self-citationPamidronate to Prevent Bone Loss during Androgen-Deprivation Therapy for Prostate Cancer
Smith, M. R., McGovern, F. J., Zietman, A. L., Fallon, M. A., Hayden, D. L., Schoenfeld, D. A., Kantoff, P. W., & Finkelstein, J. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010845 · Cited by 696
Self-citationHorwitz, E. M., Bae, K., Hanks, G. E., Porter, A., Grignon, D. J., Brereton, H. D., Venkatesan, V., Lawton, C. A., Rosenthal, S. A., Sandler, H. M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.9021 · Cited by 688
Self-citationPotosky, A. L., Davis, W. W., Hoffman, R. M., Stanford, J. L., Stephenson, R. A., Penson, D. F., & Harlan, L. C. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh259 · Cited by 680
SMITH, M. R., EASTHAM, J., GLEASON, D. M., SHASHA, D., TCHEKMEDYIAN, S., & ZINNER, N. (2003) · Journal of Urology · doi:10.1097/01.ju.0000063820.94994.95 · Cited by 650
Self-citationRoach, M., Bae, K., Speight, J., Wolkov, H. B., Rubin, P., Lee, R. J., Lawton, C., Valicenti, R., Grignon, D., & Pilepich, M. V. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9881 · Cited by 649
Self-citationStephenson, A. J., Scardino, P. T., Eastham, J. A., Bianco, F. J., Dotan, Z. A., Fearn, P. A., & Kattan, M. W. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj190 · Cited by 623
Self-citationBill-Axelson, A., Holmberg, L., Filen, F., Ruutu, M., Garmo, H., Busch, C., Nordling, S., Haggman, M., Andersson, S.-O., Bratell, S., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn255 · Cited by 603
Sakr, W. A., Grignon, D. J., Crissman, J. D., Heilbrun, L. K., Cassin, B. J., Pontes, J. J., & Haas, G. P. (1994) · PubMed · Cited by 575
Loblaw, D. A., Virgo, K. S., Nam, R., Somerfield, M. R., Ben-Josef, E., Mendelson, D. S., Middleton, R., Sharp, S. A., Smith, T. J., Talcott, J., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.1949 · Cited by 555
Adib, R., Anderson, J., Ashken, M. H., Baumber, C. D., CRA, B. D., BEYNON, L. L., Blaxland, J. W., Boag, V., Bolger, J., Boreham, J., et al. (1997) · Kent Academic Repository (University of Kent) · Cited by 551
Self-citationAndrogen deprivation therapy increases cardiovascular morbidity in men with prostate cancer
Saigal, C. S., Gore, J. L., Krupski, T. L., Hanley, J., Schonlau, M., & Litwin, M. S. (2007) · Cancer · doi:10.1002/cncr.22933 · Cited by 542
Androgen Deprivation Therapy for Localized Prostate Cancer and the Risk of Cardiovascular Mortality
Tsai, H. K., D'Amico, A. V., Sadetsky, N., Chen, M.-H., & Carroll, P. R. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm168 · Cited by 520
Self-citationSmall, E. J., Halabi, S., Dawson, N. A., Stadler, W. M., Rini, B. I., Picus, J., Gable, P., Torti, F. M., Kaplan, E., & Vogelzang, N. J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.037 · Cited by 504
Memorial Sloan Kettering Cancer Center
(2015) · The SAGE Encyclopedia of Cancer and Society · doi:10.4135/9781483345758.n370 · Cited by 502
D'Amico, A. V., Denham, J. W., Crook, J., Chen, M.-H., Goldhaber, S. Z., Lamb, D. S., Joseph, D., Tai, K.-H., Malone, S., Ludgate, C., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.3369 · Cited by 501
Self-citationInsulin sensitivity during combined androgen blockade for prostate cancer
Smith, M. R., Lee, H., & Nathan, D. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2507 · Cited by 493
Self-citationMakarov, D. V., Trock, B. J., Humphreys, E. B., Mangold, L. A., Walsh, P. C., Epstein, J. I., & Partin, A. W. (2007) · Urology · doi:10.1016/j.urology.2007.03.042 · Cited by 483
Self-citationSmith, J. C., Bennett, S., Evans, L. M., Kynaston, H. G., Parmar, M., Mason, M. D., Cockcroft, J. R., Scanlon, M. F., & Davies, J. S. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7851 · Cited by 458
PROGRESSIVE OSTEOPOROSIS DURING ANDROGEN DEPRIVATION THERAPY FOR PROSTATE CANCER
DANIELL, H. W., DUNN, S. R., FERGUSON, D. W., LOMAS, G., NIAZI, Z., & STRATTE, P. T. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)68000-7 · Cited by 452
STEWART, C. S., Leibovich, B. C., Weaver, A. L., & Lieber, M. M. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)66083-1 · Cited by 438
Outcomes of Localized Prostate Cancer Following Conservative Management
Lu-Yao, G. L. (2009) · JAMA · doi:10.1001/jama.2009.1348 · Cited by 430
CAGIANNOS, I., KARAKIEWICZ, P., EASTHAM, J. A., OHORI, M., RABBANI, F., GERIGK, C., REUTER, V., GRAEFEN, M., HAMMERER, P. G., ERBERSDOBLER, A., et al. (2003) · Journal of Urology · doi:10.1097/01.ju.0000091805.98960.13 · Cited by 402
Self-citationD'Amico, A. V., Whittington, R., Malkowicz, S. B., Fondurulia, J., Chen, M.-H., Kaplan, I., Beard, C. J., Tomaszewski, J. E., Renshaw, A. A., Wein, A., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.168 · Cited by 389
Self-citationSmith, M. R., Lee, W. C., Brandman, J., Wang, Q., Botteman, M., & Pashos, C. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.6908 · Cited by 366
Self-citationD'Amico, A. V., Whittington, R., Malkowicz, S. B., Cote, K., Loffredo, M., Schultz, D., Chen, M., Tomaszewski, J. E., Renshaw, A. A., Wein, A., et al. (2002) · Cancer · doi:10.1002/cncr.10657 · Cited by 356
Self-citationActive Surveillance for Prostate Cancer: For Whom?
Klotz, L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.3134 · Cited by 353
KATTAN, M. W., EASTHAM, J. A., WHEELER, T. M., MARU, N., SCARDINO, P. T., ERBERSDOBLER, A., GRAEFEN, M., HULAND, H., KOH, H., SHARIAT, S. F., et al. (2003) · Journal of Urology · doi:10.1097/01.ju.0000091806.70171.41 · Cited by 350
Self-citationANATOMICAL EXTENT OF LYMPH NODE DISSECTION: IMPACT ON MEN WITH CLINICALLY LOCALIZED PROSTATE CANCER
ALLAF, M. E., PALAPATTU, G. S., TROCK, B. J., CARTER, H. B., & WALSH, P. C. (2004) · Journal of Urology · doi:10.1097/01.ju.0000140912.45821.1d · Cited by 338
Self-citationMichaelson, M. D., Kaufman, D. S., Lee, H., McGovern, F. J., Kantoff, P. W., Fallon, M. A., Finkelstein, J. S., & Smith, M. R. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.3361 · Cited by 330
Self-citationStuder, U. E., Whelan, P., Albrecht, W., Casselman, J., de Reijke, T., Hauri, D., Loidl, W., Isorna, S., Sundaram, S. K., Debois, M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.7423 · Cited by 327
DANESHMAND, S., QUEK, M. L., STEIN, J. P., LIESKOVSKY, G., CAI, J., PINSKI, J., SKINNER, E. C., & SKINNER, D. G. (2004) · Journal of Urology · doi:10.1097/01.ju.0000143448.04161.cc · Cited by 318
BERRUTI, A., DOGLIOTTI, L., TERRONE, C., CERUTTI, S., ISAIA, G., TARABUZZI, R., REIMONDO, G., MARI, M., ARDISSONE, P., DE LUCA, S., et al. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)64985-3 · Cited by 315
Docetaxel Plus Prednisone or Mitoxantrone Plus Prednisone for Advanced Prostate Cancer
Walsh, P. C. (2005) · Journal of Urology · doi:10.1016/s0022-5347(05)60500-9 · Cited by 315
Self-citationSurvival Following Primary Androgen Deprivation Therapy Among Men With Localized Prostate Cancer
Lu-Yao, G. L. (2008) · JAMA · doi:10.1001/jama.300.2.173 · Cited by 315
Robotic-assisted laparoscopic prostatectomy: What is the learning curve?
Herrell, S. D., & Smith, J. A. (2005) · Urology · doi:10.1016/j.urology.2005.06.084 · Cited by 311
MAILLEFERT, J. F., SIBILIA, J., MICHEL, F., SAUSSINE, C., JAVIER, R. M., & TAVERNIER, C. (1999) · Journal of Urology · doi:10.1016/s0022-5347(01)61639-2 · Cited by 308
Predicting the Presence and Side of Extracapsular Extension: A Nomogram for Staging Prostate Cancer
OHORI, M., KATTAN, M. W., KOH, H., MARU, N., SLAWIN, K. M., SHARIAT, S., MURAMOTO, M., REUTER, V. E., WHEELER, T. M., & SCARDINO, P. T. (2004) · Journal of Urology · doi:10.1097/01.ju.0000121693.05077.3d · Cited by 297
DOCKERY, F., BULPITT, C. J., AGARWAL, S., DONALDSON, M., & RAJKUMAR, C. (2003) · Clinical Science · doi:10.1042/cs1040195 · Cited by 294
Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer
MCLEOD, D. G., IVERSEN, P., SEE, W. A., MORRIS, T., ARMSTRONG, J., WIRTH, M. P., & the Casodex Early Prostate Cancer Trialists’ Group (2006) · BJU International · doi:10.1111/j.1464-410x.2005.06051.x · Cited by 277
Efstathiou, J. A., Bae, K., Shipley, W. U., Hanks, G. E., Pilepich, M. V., Sandler, H. M., & Smith, M. R. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.3752 · Cited by 261
Self-citationNeo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer
Kumar, S., Shelley, M., Harrison, C., Coles, B., Wilt, T. J., & Mason, M. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006019.pub2 · Cited by 257
Best Practice Statement on Cryosurgery for the Treatment of Localized Prostate Cancer
Babaian, R. J., Donnelly, B., Bahn, D., Baust, J. G., Dineen, M., Ellis, D., Katz, A., Pisters, L., Rukstalis, D., Shinohara, K., et al. (2008) · Journal of Urology · doi:10.1016/j.juro.2008.07.108 · Cited by 241
Anxiety and distress during active surveillance for early prostate cancer
van den Bergh, R. C. N., Essink‐Bot, M., Roobol, M. J., Wolters, T., Schröder, F. H., Bangma, C. H., & Steyerberg, E. W. (2009) · Cancer · doi:10.1002/cncr.24446 · Cited by 230
Radiopharmaceutical therapy for palliation of bone pain from osseous metastases.
Pandit-Taskar, N. D., Batraki, M., & Divgi, C. R. (2004) · PubMed · Cited by 224
Risk of Clinical Fractures After Gonadotropin-Releasing Hormone Agonist Therapy for Prostate Cancer
Smith, M. R., Boyce, S. P., Moyneur, E., Duh, M. S., Raut, M. K., & Brandman, J. (2006) · Journal of Urology · doi:10.1016/s0022-5347(05)00033-9 · Cited by 212
Self-citationRisks and benefits of bisphosphonates
Coleman, R. E. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604382 · Cited by 212
Pucar, D., Shukla-Dave, A., Hricak, H., Moskowitz, C. S., Kuroiwa, K., Olgac, S., Ebora, L. E., Scardino, P. T., Koutcher, J. A., & Zakian, K. L. (2005) · Radiology · doi:10.1148/radiol.2362040739 · Cited by 198
Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial
Pollack, A., Zagars, G. K., Starkschall, G., Antolak, J. A., Lee, J. J., Huang, E., von Eschenbach, A. C., Kuban, D. A., Rosen, I., & Ritter, M. A. (2003) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/s1078-1439(03)00092-9 · Cited by 192
Acute morbidity reduction using 3DCRT for prostate carcinoma: a randomized study
Koper, P. C. M., Stroom, J. C., van Putten, W. L. J., Korevaar, G. A., Heijmen, B. J. M., Wijnmaalen, A., Jansen, P. P., Hanssens, P. E. J., Griep, C., Krol, A. D. G., et al. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00406-4 · Cited by 183
Wolf, J. S., Cher, M. L., Dall’Era, M., Presti, J. C., Hricak, H., & Carroll, P. R. (1995) · PubMed · Cited by 181
Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial
Kibel, A. S. (2008) · Yearbook of Urology · doi:10.1016/s0084-4071(08)79094-8 · Cited by 178
Insignificant Prostate Cancer and Active Surveillance: From Definition to Clinical Implications
Bastian, P. J., Carter, B. H., Bjartell, A., Seitz, M., Stanislaus, P., Montorsi, F., Stief, C. G., & Schröder, F. (2009) · European Urology · doi:10.1016/j.eururo.2009.02.028 · Cited by 177
Avascular necrosis of the jaws: risk factors in metastatic cancer patients
Tarassoff, P., & Csermak, K. (2003) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2003.09.001 · Cited by 175
Graefen, M., Haese, A., Pichlmeier, U., Hammerer, P. G., Noldus, J., Butz, K., Erbersdobler, A., Henke, R., Michl, U. H. G., Fernandez, S., et al. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)66544-5 · Cited by 152
Jhaveri, F. M., Zippe, C. D., Klein, E. A., & Kupelian, P. A. (1999) · Urology · doi:10.1016/s0090-4295(99)00252-6 · Cited by 149
Gore, J. L., Kwan, L. C., Lee, S. P., Reiter, R. E., & Litwin, M. S. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp114 · Cited by 145
Screening and Prostate-Cancer Mortality in a Randomized European Study
Lawton, C. A. (2010) · Yearbook of Oncology · doi:10.1016/s1040-1741(09)79428-x · Cited by 138
Dupont, A., Gomez, J., Cusan, L., Koutsilieris, M., & Labrie, F. (1993) · The Journal of Urology · doi:10.1016/s0022-5347(17)35646-x · Cited by 133
Janjan, N. A., Lutz, S., Bedwinek, J. M., Hartsell, W. F., Ng, A. K., Pieters, R. S., Ratanatharathorn, V., Silberstein, E. B., Taub, R. J., Yasko, A. W., et al. (2009) · Journal of Palliative Medicine · doi:10.1089/jpm.2009.9633 · Cited by 122
Lefkowitz, G. K., Taneja, S. S., Brown, J. S., Melamed, J., & Lepor, H. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(05)64463-1 · Cited by 122
Labrie, F., Dupont, A., Bélanger, A., & Lachance, R. (1987) · The Journal of Urology · doi:10.1016/s0022-5347(17)43380-5 · Cited by 122
Smith, M. R., Malkowicz, S. B., Chu, F. M., Forrest, J. B., Price, D., SIEBER, P. R., Barnette, K. G., Rodriguez, D., & Steiner, M. S. (2007) · The Journal of Urology · doi:10.1016/j.juro.2007.08.137 · Cited by 118
Self-citationMichalski, J. M., Bae, K., Roach, M., Markoe, A. M., Sandler, H. M., Ryu, J. K., Parliament, M. B., Straube, W. L., Valicenti, R. K., & Cox, J. D. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.01.062 · Cited by 113
Self-citationRole of Androgen Deprivation Therapy for Node-Positive Prostate Cancer
Wong, Y., Freedland, S. J., Egleston, B. L., Hudes, G. R., Schwartz, J. S., & Armstrong, K. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2042 · Cited by 113
Smith, J. A. J., & Herrell, S. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.1963 · Cited by 112
Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden
Johansson, J.-E. (1997) · JAMA · doi:10.1001/jama.277.6.467 · Cited by 102
Eri, L. M., Urdal, P., & Bechensteen, A. G. (1995) · The Journal of Urology · doi:10.1016/s0022-5347(01)67239-2 · Cited by 100
Shappley, W. V., Kenfield, S. A., Kasperzyk, J. L., Qiu, W., Stampfer, M. J., Sanda, M. G., & Chan, J. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.2613 · Cited by 100
Machiels, J., Mazzeo, F., Clausse, M., Filleul, B., Marcelis, L., Honhon, B., D'Hondt, L. A., Dopchie, C., Verschaeve, V., Duck, L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.9524 · Cited by 90
Berthold, D., Pond, G. R., deWit, R., Eisenberger, M., & Tannock, I. F. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.5005 · Cited by 90
Swanson, G. P., Goldman, B. H., Tangen, C. M., Chin, J. L., Messing, E. M., Canby‐Hagino, E., Forman, J. D., Thompson, I. M., & Crawford, E. D. (2008) · The Journal of Urology · doi:10.1016/j.juro.2008.08.037 · Cited by 89
Davis, J. W., Chang, D. W., Chevray, P. M., Wang, R., Shen, Y., Wen, S., Pettaway, C. A., Pisters, L. L., Swanson, D. A., Madsen, L. T., et al. (2008) · European Urology · doi:10.1016/j.eururo.2008.08.051 · Cited by 84
Smith, M. R., Malkowicz, S. B., Chu, F. M., Forrest, J. B., SIEBER, P. R., Barnette, K. G., Rodriquez, D., & Steiner, M. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.5517 · Cited by 80
Self-citationHanlon, A. L., Bruner, D. W., Peter, R. S., & Hanks, G. E. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)01365-1 · Cited by 78
Tayek, J., Heber, D., Byerley, L., Steiner, B., Rajfer, J., & Swerdloff, R. S. (1990) · Metabolism: Clinical and Experimental · doi:10.1016/0026-0495(90)90190-n · Cited by 78
D'Amico, A. V., Moran, B. J., Braccioforte, M. H., Dosoretz, D. E., Salenius, S. A., Katin, M. J., Ross, R., & Chen, M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.3992 · Cited by 77
Self-citationKibel, A. S. (2006) · Yearbook of Urology · doi:10.1016/s0084-4071(08)70375-0 · Cited by 63
Shekarriz, B. M., Upadhyay, J., & Pontes, J. E. (2001) · Urologic Clinics of North America · doi:10.1016/s0094-0143(05)70162-2 · Cited by 53
Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
Clarke, B. L. (2010) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(10)79521-4 · Cited by 51
McLeod, D. G., See, W. A., Klimberg, I. W., Gleason, D. M., Chodak, G. W., Montie, J. E., Bernstein, G., Morris, C. D., Armstrong, J., & Casodex™ Early Prostate Cancer Trialists’ Group (2006) · The Journal of Urology · doi:10.1016/s0022-5347(06)00495-2 · Cited by 46
Walsh, P. C. (2005) · The Journal of Urology · doi:10.1016/s0022-5347(05)60498-3 · Cited by 44
Self-citationRisk of Clinical Fractures After Gonadotropin-Releasing Hormone Agonist Therapy for Prostate Cancer
Smith, M. R., Boyce, S. P., Moyneur, É., Duh, M. S., Raut, M. K., & Brandman, J. (2006) · The Journal of Urology · doi:10.1097/00005392-200601000-00035 · Cited by 25
Self-citation
Cited by
Castro, E., Goh, C., Olmos, D., Saunders, E., Leongamornlert, D., Tymrakiewicz, M., Mahmud, N., Dadaev, T., Govindasami, K., Guy, M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.1882 · Cited by 850
Smith, M. R., Saad, F., Coleman, R., Shore, N., Fizazi, K., Tombal, B., Miller, K., Sieber, P., Karsh, L., Damião, R., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61226-9 · Cited by 797
Self-citationBriganti, A., Larcher, A., Abdollah, F., Capitanio, U., Gallina, A., Suardi, N., Bianchi, M., Sun, M., Freschi, M., Salonia, A., et al. (2012) · European Urology · doi:10.1016/j.eururo.2011.10.044 · Cited by 786
Active Surveillance for Prostate Cancer: A Systematic Review of the Literature
Dall’Era, M. A., Albertsen, P. C., Bangma, C., Carroll, P. R., Carter, H. B., Cooperberg, M. R., Freedland, S. J., Klotz, L. H., Parker, C., & Soloway, M. S. (2012) · European Urology · doi:10.1016/j.eururo.2012.05.072 · Cited by 602
Active Surveillance Program for Prostate Cancer: An Update of the Johns Hopkins Experience
Tosoian, J. J., Trock, B. J., Landis, P., Feng, Z., Epstein, J. I., Partin, A. W., Walsh, P. C., & Carter, H. B. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.8112 · Cited by 596
Self-citation
Metadata
- Authors
- Mohler, J., Bahnson, R. R., Boston, B., Busby, J. E., D'Amico, A., Eastham, J. A., Enke, C. A., George, D., Horwitz, E. M., Huben, R. P., Kantoff, P., Kawachi, M., Kuettel, M., Lange, P. H., MacVicar, G., Plimack, E. R., Pow-Sang, J. M., Roach, M., Rohren, E., Roth, B. J., Shrieve, D. C., Smith, M. R., Srinivas, S., Twardowski, P., & Walsh, P. C.
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2010-02
- Volume
- 8
- Issue
- 2
- Pages
- 162-200
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W49263098
- Cited by
- 897
- References
- 122
- FWCI
- 74.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.